Correvio Pharma Corp. Interest Expense on Debt
Correvio Pharma Corp. reported Interest Expense on Debt of $7.51 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2020-04-30
| Period end | Interest Expense, Debt 12 month | Interest Expense, Debt 12 month as first filed |
|---|---|---|
| 2019-12-31 | $7.51M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $5.98M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $5.70M 20-F · filed 2020-04-30 | |
| 2016-12-31 | $2.54M 20-F · filed 2018-04-30 | |
| 2015-12-31 | $2.26M 20-F · filed 2018-04-30 | |
| 2014-12-31 | $1.48M 40-F · filed 2016-03-29 | |
| 2013-12-31 | $87.00K 40-F · filed 2015-03-27 | |
| 2012-12-31 | $4.27M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $2.22M 20-F/A · filed 2013-04-18 | -$2.22M 40-F/A · filed 2012-04-25 |
| 2010-12-31 | $1.98M 20-F/A · filed 2013-04-18 | -$1.98M 40-F/A · filed 2012-04-25 |